Six checks separate a study worth believing from a study worth a headline. Each check below comes with a real example from the verified sea buckthorn corpus, the same papers the marketing quotes. Five minutes with this page and you can grade any study a label throws at you.
Check 1: Was it human?
The evidence ladder runs cell dish, animal, human. Sea buckthorn has hundreds of cell and animal papers, and they cannot support a human claim, because most compounds that work in rodents fail in people. The cancer research page is the site’s standing lesson: real laboratory findings, zero human trials, no consumer claims allowed. When a product page cites research, the first question is which rung of the ladder the paper sits on.
Check 2: How many people, and for how long?
Sample size disciplines every percentage. The platelet study that drives our safety cautions had 12 healthy men for 4 weeks. The flagship dry-eye trial had 100 for three months. The berries-and-colds trial had about 250. And the strongest evidence this plant has is a meta-analysis pooling 15 randomized trials, because pooling is how science compensates for small studies. One small trial is a signal. Many small trials pointing the same way become a finding.
Check 3: Was there a placebo?
This is the check the sea buckthorn skin literature teaches best. A 2009 study gave women 2 grams of oral oil daily for three months and measured hydration up 48.6 percent, but the oral arm had no placebo group. A 2024 trial measured the same outcome against a real placebo and found hydration up 8 percent. Both numbers are published, and the gap between them is what expectation, season, and regression to the mean look like. The skin studies page runs the full comparison. Uncontrolled studies produce big numbers. Controlled studies produce true ones, which are usually smaller.
Check 4: Who paid?
The 2024 trial was industry-funded, run with a branded oil from the company that sells it, and we say so wherever we cite it. Funding does not falsify a result: the trial was placebo-controlled and its modest numbers are credible. But funded research as a literature skews favorable, so a brand-funded positive counts for less than an independent one. The check takes ten seconds, because funding statements sit at the end of every paper. A label quoting a study without its funding line has done your homework badly on purpose.
Check 5: Where was it published?
Journal quality is a screen, not a verdict, and PubMed indexing is the fastest version of it. The 2009 skin study appeared in the Journal of Applied Cosmetology, which is not PubMed-indexed, so we link the hosted PDF and label it exactly that way. Most of the corpus, from the dry-eye trial to the lipid meta-analysis, sits in indexed journals with PMIDs you can verify in one click. Absence from the index does not make a study fake. It removes one layer of quality control, and your confidence should adjust.
Check 6: Is the dose realistic?
Ask what the participants actually took and whether you would. The platelet finding required 5 grams of oil daily, about ten standard softgels, for four weeks. The blood-pressure trial used 0.75 ml of seed oil, a few drops. The berries trial used 28 grams of fruit, a real snack. Doses decide both what a result means and what it costs, and the study dosages page tabulates every one.
That last one is the realism check working for the science: a dose a person can actually eat, which is why its null result carries weight that a lab-bench dose never could.
Two worked examples, start to finish
The headline: “Studies show sea buckthorn boosts skin hydration by 49 percent.” Run the drill. Human, yes. Placebo, no: the oral arm had none, and the 49 percent comes from the weaker design, while the placebo-controlled trial found 8. Who paid, a brand-linked oil. Which journal, outside the PubMed index. What dose, 2 grams a day for three months, which the label quoting it rarely mentions. Verdict: a real measurement from the weakest-controlled study in the pair, quoted at maximum size.
The blood marker: “Sea buckthorn raises antioxidant enzymes 82.8 percent.” Run the drill. Human and placebo-controlled, good. How many: 40 people, and the enzyme was a secondary endpoint beside the skin outcomes the trial was built around. Secondary markers in small samples swing on a few strong responders, so the honest version reads: an interesting blip worth a bigger study. The skin outcomes from the same trial, 8 to 14 percent, are what a primary endpoint at that sample size looks like.
The claims that fail every check at once
You will meet them: sea buckthorn for weight loss, blood sugar control, immune boosting, detox. Each fails check one immediately, because no human trial tested the claim, and the closest human data points the other way: the pooled trials found no effect on BMI, glucose, or blood pressure, and the berry trial found no effect on colds. The cholesterol meta-analysis page prints those nulls next to the positives, and the omega-7 audit shows the splice that manufactures such claims from mouse studies.
The five-minute drill
Human? Placebo? How many, how long? Who paid? Which journal? What dose? Six questions, one verdict, and the answer is usually a shade of gray rather than yes or no. Our research method applies the same drill with a grading scale attached, the clinical trials catalog shows the graded results, the blood thinners page shows how one small study becomes a practical caution, and the research hub is where the graded corpus lives.
The dry-eye dissection is the drill applied at full length to the best trial this plant has, and the editorial policy is the standing offer to correct us when we fail our own checks.
Frequently asked questions
What is the biggest red flag in a sea buckthorn study?
The fastest three checks: was it human, was there a placebo group, and who paid. Cell and animal studies cannot support human claims. Uncontrolled human studies produce inflated numbers, as the placebo-free skin study with its 49 percent hydration claim shows against the placebo-controlled 8 percent. Industry funding does not falsify a result, but it discounts it, and we say which studies carry it.
What is the single fastest red flag?
A claim stronger than the design behind it. Mouse data sold as human benefit, a placebo-free number sold as proven, a secondary marker sold as the headline: every supplement exaggeration is some version of that one mismatch. Match every claim to the design that could possibly support it and most marketing collapses on the spot, which is why the six checks all end at the same question.